Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Indostar Capital Finance Ltd.
Source DateBoard Meeting DateDetails
27-Jan-2026 09-Feb-2026 Quarterly Results (Revised)
20-Jan-2026 29-Jan-2026 Quarterly Results
23-Oct-2025 30-Oct-2025 Quarterly Results
07-Aug-2025 13-Aug-2025 Quarterly Results
23-Apr-2025 29-Apr-2025 Audited Results
13-Jan-2025 20-Jan-2025 Quarterly Results
10-Oct-2024 18-Oct-2024 Quarterly Results
26-Aug-2024 29-Aug-2024 Inter alia, to consider and approve:- i. issue of Non-Convertible Debentures for an amount not exceeding INR 6,000 crore on private placement basis, during a year from the date of the approval of the shareholders; ii. amendment to the Articles of Association of the Company, to incorporate specific clause relating to authorizing Debenture Trustees to appoint nominee director in terms of clause (e) of sub-regulation (1) of regulation 15 of the Securities and Exchange Board of India (Debenture Trustees) Regulations, 1993.
24-Jul-2024 31-Jul-2024 Quarterly Results
17-Apr-2024 29-Apr-2024 Board Meeting Intimation for Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 (Listing Regulations) Board Meeting 0.23 MB XBRLIndostar Capital Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 ,inter alia, to consider and approve we wish to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 29 April 2024, inter-alia the following matters: (i) Consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended 31 March 2024; (ii) Consider recommendation of dividend, if any, on equity shares of the Company, for the financial year ended 31st March 2024 for approval of the shareholders at the ensuing Annual General Meeting; (iii) Consider and approve issue of Non-Convertible Debentures for an amount not exceeding INR 6,000 crore in year through private placement.
22-Feb-2024 27-Feb-2024 Issue Of Warrants Inter alia, to consider and evaluate a proposal for raising of funds by way of issue of one or more instrument/securities including equity shares, convertible securities of any description or warrants or debt securities, through preferential issue on a private placement basis, rights issue or any other methods or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required. The Board of Directors, if required, would also consider convening an extra-ordinary general meeting/ postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal, as required.
18-Jan-2024 24-Jan-2024 Quarterly Results Inter alia, to consider and approve the following:- On account of re-constitution of Borrowing/Debenture Committee of the Company, to approve and pass resolutions in supersession of the earlier resolutions passed pursuant to Borrowings of the Company
19-Oct-2023 27-Oct-2023 Quarterly Results
17-Aug-2023 21-Aug-2023 A.G.M.
26-Jul-2023 02-Aug-2023 Quarterly Results & Inter alia, to consider and approve:- (i) To consider and approve issue of Non-Convertible Debentures for an amount not exceeding INR 7,500 crore in year through private placement.
17-May-2023 25-May-2023 Audited Results
06-Feb-2023 14-Feb-2023 Quarterly Results
02-Nov-2022 08-Nov-2022 Quarterly Results
08-Aug-2022 14-Aug-2022 Quarterly Results Inter alia, to consider and approve:- (i) Issue of Non-Convertible Debentures ("NCD") on private placement basis, in one or more tranches from time to time, subject to the approval of shareholders of the Company; (ii) Convening 13th AGM to seek approval of shareholders inter-alia for issue of NCD for an amount not exceeding INR 3,000 crore on private placement basis, during a year from the date of the approval of the shareholders.
25-Jul-2022 05-Aug-2022 Audited Results
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.